|
KIAA0317 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52331999999644E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82500000000174E-05 |
| Normal-vs-Stage2 |
4.197800E-04 |
| Normal-vs-Stage3 |
1.238260E-03 |
| Normal-vs-Stage4 |
9.73190000030932E-07 |
| Stage1-vs-Stage2 |
6.649600E-01 |
| Stage1-vs-Stage3 |
3.586000E-01 |
| Stage1-vs-Stage4 |
5.509800E-02 |
| Stage2-vs-Stage3 |
7.381800E-01 |
| Stage2-vs-Stage4 |
6.959700E-02 |
| Stage3-vs-Stage4 |
2.587200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58636999999517E-05 |
| Normal-vs-AfricanAmerican |
8.25010000000681E-05 |
| Normal-vs-Asian |
2.722900E-03 |
| Caucasian-vs-AfricanAmerican |
7.544000E-01 |
| Caucasian-vs-Asian |
5.672400E-01 |
| AfricanAmerican-vs-Asian |
6.221000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.38879999994823E-06 |
| Normal-vs-Female |
1.560670E-03 |
| Male-vs-Female |
4.513600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.85856000000095E-05 |
| Normal-vs-Extreme_Weight |
4.1897000000457E-06 |
| Normal-vs-Obese |
1.583920E-03 |
| Normal-vs-Extreme_Obese |
3.810200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.071600E-01 |
| Normal_Weight-vs-Obese |
1.730380E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.152400E-01 |
| Extreme_Weight-vs-Obese |
2.570200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.956600E-01 |
| Obese-vs-Extreme_Obese |
6.344000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.043600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.180580E-03 |
| Normal-vs-Age(61-80Yrs) |
1.67610000001428E-06 |
| Normal-vs-Age(81-100Yrs) |
2.30969999792663E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.315200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.780000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.704380E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.449560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.152600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.816390E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.562220E-03 |
| Normal-VS-Type2 PRCC |
2.19459994621474E-09 |
| Normal-VS-KIRP CIMP |
3.201000E-03 |
| Normal-VS-Unclassified PRCC |
1.583970E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.09839999999862E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.646400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.515400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.009400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.054400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.419200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.92940005375675E-09 |
| Normal-vs-N1 |
2.637700E-04 |
| Normal-vs-N2 |
2.24799999999359E-05 |
| N0-vs-N1 |
3.290400E-01 |
| N0-vs-N2 |
8.770300E-02 |
| N1-vs-N2 |
8.199800E-02 |
|
|
